title: Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009-2010 season: web-based and telephone evaluation.
abstract: BACKGROUND
  There has been worldwide interest in the safety of the pandemic influenza A (H1N1p) vaccines, although limited data are available from the vaccine recipients' perspective. This evaluation was designed to collect data from people who had received an influenza vaccination during the 2009-2010 season using a web-based data collection tool supplemented by telephone reporting (PROBE).
  
  
  METHODS
  People scheduled to receive the influenza A (H1N1p) or seasonal influenza vaccines were recruited through media advertising and campaigns throughout the West of Scotland. Vaccine recipients participated in the evaluation by answering demographic and side effect questions using PROBE methodology on the day of the immunization, after 3 days, 8 days, 6 weeks, 12 weeks, and 26 weeks.
  
  
  RESULTS
  A total of 1103 vaccine recipients including 134 young children (0-4 years) participated in the evaluation; 694 (63%) received H1N1p vaccine only, 135 (12%) seasonal vaccine only, 224 (20%) both H1N1p and seasonal vaccines, and 50 (5%) received H1N1p or seasonal vaccine with a non-influenza vaccine (eg, travel or pneumococcal). Overall, 42% of recipients reported experiencing a side effect after their baseline vaccination; the most commonly reported were general and arm side effects (>20%). Injection site discomfort/pain and flu-like symptoms were reported by 57% and 24% of recipients, respectively. A significantly higher proportion of the 960 H1N1p vaccine recipients experienced a side effect (44% vs 27%, P < 0.001) or injection site discomfort/pain (61% vs 26%, P < 0.001) than those receiving seasonal influenza vaccines. Female sex and H1N1p vaccination were associated with a significantly higher risk of injection site discomfort/pain, whereas the 70+ age group was associated with a significantly lower risk. H1N1p vaccine was well tolerated by children under 5 years with side effects reported at a similar frequency to that found in the total population.
  
  
  CONCLUSIONS
  Safety and tolerability data from influenza vaccine recipients including young children (via parents/carers) can be effectively collected using an online questionnaire with a telephone option (PROBE). The influenza A (H1N1p) vaccine was well tolerated, but was associated with more local short-term reactions than the seasonal influenza vaccine.
authors.affiliation: Patients Direct, 3 Todd Campus, Glasgow, UK.
authors.forename: Alan G
authors.initials: AG
authors.lastname: Wade
authors.forename: Gordon M
authors.initials: GM
authors.lastname: Crawford
authors.forename: Neil
authors.initials: N
authors.lastname: Pumford
authors.forename: Alex
authors.initials: A
authors.lastname: McConnachie
references.citation: BMJ. 2010 May 27;340:c2649
references.pmid: 20508026
references.citation: Vaccine. 2010 Feb 17;28(7):1740-5
references.pmid: 20034605
references.citation: N Engl J Med. 2008 Jun 12;358(24):2573-84
references.pmid: 18550874
references.citation: Wkly Epidemiol Rec. 2009 Dec 4;84(49):505-8
references.pmid: 19960623
references.citation: Lancet. 2010 Jan 2;375(9708):49-55
references.pmid: 20018367
references.citation: Lancet. 2009 Dec 19;374(9707):2115-2122
references.pmid: 19880172